“Genomics companies will never be self-sufficient as long as they sell services only. Those who develop therapeutics might have a chance.”
— Alex Zisson, Senior Research Analyst and Managing Director, Research Department, JP Morgan, speaking at The Economist’s Pharmaceuticals 2001 conference